Table 1 Profile of laboratory data for a diabetes patient with thyrotoxicosis due to painless thyroiditis
From: A case of thyrotoxicosis-induced anemia in a patient with painless thyroiditis
Variables | Reference range | Day − 56 | Day −28 | Day 0 | Day 14 | Day 28 | Day 56 | Day 84 | Day 112 | Day 140 | Day 168 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Red blood cells, 1012/l | 4.27–5.70 | 4.80 | 4.96 | 3.78 | 3.77 | 3.84 | 4.50 | 4.77 | 4.93 | 4.88 | 4.66 |
Hemoglobin (Hgb), g/l | 135–176 | 144 | 146 | 110 | 107 | 109 | 126 | 136 | 142 | 146 | 140 |
Hematocrit (Hct), /l | 0.398–0.518 | 0.399 | 0.408 | 0.308 | 0.305 | 0.306 | 0.352 | 0.377 | 0.392 | 0.386 | 0.408 |
Mean corpuscular volume (MCV), fl | 81.7–101.6 | 83.1 | 82.3 | 81.5 | 80.9 | 79.7 | 78.2 | 79.0 | 79.5 | 82.8 | 83.4 |
White blood cells (WBC), 109 /l | 3.5–9.8 | 6.4 | 7.4 | 5.3 | 7.2 | 6.5 | 8.8 | 8.6 | 8.8 | 5.8 | 7.4 |
Platelets, 109 /l | 130–369 | 272 | 315 | 254 | 198 | 228 | 289 | 266 | 283 | 322 | 333 |
Reticulocytes, 109 /l | 30–100 | 108 | 68 | ||||||||
Thyroid stimulating hormone (TSH), mIU/l | 0.50–5.00 | < 0.01 | < 0.01 | < 0.01 | < 0.01 | 10.1 | 15.2 | 18.5 | |||
Free triiodothyronine (FT3), pmol/l | 3.53–6.14 | 27.49 | 12.61 | 9.37 | 3.93 | 4.35 | 4.22 | ||||
Free thyroxine (FT4), pmol/l | 11.6–21.9 | 100.4 | 91.4 | 51.5 | 33.1 | 14.0 | 13.1 | 14.0 | |||
TSH receptor antibody (TRAb), mIU/l | < 2.0 | 0.4 | |||||||||
Anti-TPO antibody, IU/ml | < 16 | 9 | |||||||||
Ant-thyroglobulin antibody, IU/ml | < 28 | 11 | |||||||||
C-reactive protein (CRP), μg/l | < 3000 | 6900 | 12,100 | 5700 | 3700 | 1200 | |||||
Iron (Fe), μmol/l | 9.1–35.5 | 9.5 | 9.5 | ||||||||
TIBC, μmol/l | 43.2–69.0 | 34.2 | 40.8 | ||||||||
Ferritin, μg/l | 13–401 | 389 | 376 | 396 | |||||||
Haptoglobin, g/dl | 0.19–1.70 | 0.66 | |||||||||
Soluble IL-2 receptor (sIL-2R), U/ml | 122–496 | 1340 | 1010 | 808 | 472 | 365 | |||||
HDL-C, mmol/l | 1.03–2.48 | 1.27 | 1.09 | 0.75 | 0.98 | 1.27 | 1.42 | 1.14 | 1.16 | 1.14 | |
LDL-C, mmol/l | 1.68–3.59 | 1.99 | 1.63 | 0.78 | 1.45 | 2.12 | 2.82 | 2.87 | 2.90 | 2.82 | |
Triglycerides (TG), mmol/l | 0.34–1.68 | 0.46 | 0.59 | 0.54 | 0.84 | 0.68 | 0.75 | 0.84 | 0.59 | 0.60 | |
HbA1c (NGSP), % | 4.6–6.2 | 6.9 | 7.1 | 7.6 | 6.5 | 6.6 | 6.9 | 7.7 | 7.6 | 7.5 | |
AST, IU/l | 13–33 | 19 | 18 | 21 | 25 | 30 | 25 | 22 | 27 | 23 | |
ALT, IU/l | 6–30 | 13 | 14 | 19 | 28 | 29 | 21 | 15 | 22 | 21 | |
γGTP, IU/l | 10–47 | 13 | 14 | 21 | 42 | 57 | 37 | 26 | 20 | 19 | |
Albumin, g/l | 40–50 | 41 | 42 | 31 | 32 | 36 | 36 | 35 | 41 | 41 | |
eGFR, ml/min/1.73 m2 | > 60 | 103 | 97 | 111 | 115 | 104 | 90 | 88 | 79.0 | 80.0 | |
Drug treatment | Propranolol 30 mg | Propranolol 30 mg | LT4 12.5 μg |